Compare Orion Office REIT Inc (ONL) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Orion Office REIT Inc vs TransMedics Group Inc — how do they compare? Orion Office REIT Inc trades at $2.18 (market cap $125.50M), while TransMedics Group Inc trades at $78.15 (market cap $2.74B). The key difference: TransMedics Group Inc is far larger — about 21.8× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 3.64% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Orion Office REIT Inc for 33 Days and TransMedics Group Inc for 24 Days on average.
| ONL | TMDX | |
|---|---|---|
Market Cap | $125.50M | $2.74B |
Volume | 303,276 | 949,331 |
Sector | Real Estate | Health |
52-Week High | $3.00 | $150.42 |
52-Week Low | $1.93 | $61.99 |
Typical Hold Time | 33 Days | 24 Days |
Enterprise Value | $542.43M | $3.13B |
Dividend Yield | 3.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ONL trades at $2.17, down 4.41% today, with a bearish technical signal from moving averages but bullish oscillators. The REIT shows declining revenue from $208M in 2022 to $148M in 2025, with persistent net losses widening to -$139M. Valuation metrics include P/S of 0.88 and P/B of 0.2, suggesting potential undervaluation, while analyst consensus is split evenly between Buy and Hold ratings. Recent news highlights strategic portfolio repositioning and a declared $0.02 dividend for H2-26.
Outlook remains challenged by operational losses and high leverage, though deep asset discounts and strategic reviews may offer turnaround potential. Key risks include sustained negative margins, debt servicing pressures, and office sector headwinds. Investment appeal hinges on execution of repositioning efforts and margin recovery.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
